tiprankstipranks
China Resources Pharmaceutical Group Ltd. (DE:640)
:640
Germany Market

China Resources Pharmaceutical Group Ltd. (640) Financial Statements

Compare
0 Followers

China Resources Pharmaceutical Group Ltd. Financial Overview

China Resources Pharmaceutical Group Ltd.'s market cap is currently €4.10B. The company's EPS TTM is €; its P/E ratio is 7.93; and it has a dividend yield of 4.85%. China Resources Pharmaceutical Group Ltd. is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueHK$ 270.40BHK$ 254.11BHK$ 236.81BHK$ 200.42BHK$ 204.45B
Gross ProfitHK$ 43.37BHK$ 39.13BHK$ 35.38BHK$ 32.29BHK$ 34.02B
Operating IncomeHK$ 12.15BHK$ 10.81BHK$ 9.25BHK$ 8.47BHK$ 8.02B
EBITDAHK$ 15.43BHK$ 15.47BHK$ 11.95BHK$ 12.47BHK$ 12.58B
Net IncomeHK$ 3.85BHK$ 3.50BHK$ 3.08BHK$ 2.78BHK$ 3.29B
Balance Sheet
Cash & Short-Term InvestmentsHK$ 59.27BHK$ 32.52BHK$ 37.32BHK$ 52.34BHK$ 22.79B
Total AssetsHK$ 271.48BHK$ 241.29BHK$ 248.56BHK$ 209.37BHK$ 190.03B
Total DebtHK$ 62.16BHK$ 67.00BHK$ 82.59BHK$ 58.63BHK$ 54.52B
Net DebtHK$ 37.51BHK$ 42.88BHK$ 57.26BHK$ 40.91BHK$ 37.39B
Total LiabilitiesHK$ 169.20BHK$ 150.24BHK$ 152.69BHK$ 128.69BHK$ 119.84B
Stockholders' EquityHK$ 50.60BHK$ 49.56BHK$ 50.98BHK$ 46.47BHK$ 40.71B
Cash Flow
Free Cash FlowHK$ 12.42BHK$ 7.54BHK$ 8.32BHK$ 4.06BHK$ 3.21B
Operating Cash FlowHK$ 15.55BHK$ 10.90BHK$ 11.22BHK$ 6.28BHK$ 5.25B
Investing Cash FlowHK$ -2.07BHK$ -3.30BHK$ -8.83BHK$ -2.02BHK$ 1.04B
Financing Cash FlowHK$ -4.47BHK$ -9.00BHK$ 5.31BHK$ -3.60BHK$ -9.10B
Currency in HKD

China Resources Pharmaceutical Group Ltd. Earnings and Revenue History

China Resources Pharmaceutical Group Ltd. Debt to Assets

China Resources Pharmaceutical Group Ltd. Cash Flow

China Resources Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis